the value of mrd as a prognostic tool in myeloma
Published 2 years ago • 339 plays • Length 5:18Download video MP4
Download video MP3
Similar videos
-
1:36
the importance of mrd as a prognostic tool in multiple myeloma
-
4:16
the prognostic value of mrd in multiple myeloma & mrd-guided therapy
-
4:22
prognostic value of mrd and circulating plasma cells in myeloma
-
2:11
mrd as a predictor of risk in myeloma
-
3:27
mrd negativity using deep sequencing is a major prognostic factor in myeloma
-
1:37
mrd in myeloma
-
1:26
mrd in myeloma: the fda perspective
-
2:17
mrd: a promising biomarker in multiple myeloma
-
3:37
biomarker analysis of luspatercept versus epoetin alfa in lr-mds in the phase iii commands study
-
50:02
trends in multiparameter flow cytometry in hematology - dr. brent wood
-
2:23
the significance of variant allele frequency in patients with sf3b1-mutated mds
-
0:48
myeloma prognosis - the emergence of mrd
-
1:20
mrd in myeloma
-
6:33
mrd as a tool to discontinue therapy in mm?
-
3:15
the evolution of mrd for myeloma
-
3:10
the importance of mrd in multiple myeloma in guiding treatment decisions & access to therapies
-
2:25
master final analysis: quadruplet induction therapy, asct & mrd-adapted treatment cessation in ndmm
-
1:23
the value of mrd as a marker for disease eradication in aml
-
2:03
prognostic significance of molecular mrd in npm1-mutated aml treated with venetoclax-based therapy
-
1:46
the assets of mrd in myeloma
-
2:18
new applications for mrd measurement in myeloma: mrd 'over time'
-
2:46
managing patients with high-risk myeloma